Showing results (861-870 of 1,251) with videos related to

Sort By:
Pageof 126
Jac-Antimicrobial Resistance|February 8, 2024
Should we stop referring to the pandemic of antimicrobial resistance as silent?Miroslav Sirota
Jac-Antimicrobial Resistance|March 25, 2024
The antibiotic knowledge, attitudes and behaviours of patients purchasing antibiotics with prescription in Russia: a qualitative, comparative analysisSvetlana Rachina, Polina Zakharenkova, Roman Kozlov, et al.
Jac-Antimicrobial Resistance|March 26, 2024
Carbapenem-resistant Klebsiella pneumoniae among hospitalized patients in Cape Town, South Africa: molecular epidemiology and characterizationGert Marais, Clinton Moodley, Shantelle Claassen-Weitz, et al.
Jac-Antimicrobial Resistance|March 29, 2024
Antimicrobial resistance of clinical bacterial isolates in China: current status and trendsXiaohua Qin, Li Ding, Min Hao, et al.
Jac-Antimicrobial Resistance|February 12, 2024
Experiences of an inpatient penicillin allergy de-labelling pathway: capturing the patient voiceNeil Powell, Mathew Upton, Bridie Kent, et al.
Jac-Antimicrobial Resistance|February 12, 2024
Trends in antibiotic prescribing in primary care out-of-hours doctors' services in IrelandMala Shah, Teresa M Barbosa, Gary Stack, et al.
Jac-Antimicrobial Resistance|March 13, 2024
Where to start? The Irish Emergency Department Antimicrobial Discharge (EDAD) study: a multicentre, prospective cohort analysisAisling Rafferty, Alida Fe Talento, Richard Drew, et al.
Jac-Antimicrobial Resistance|March 7, 2024
14-Year Epidemiologic study of Pseudomonas aeruginosa bloodstream infection incidence and resistance in the Veterans Health Administration system, 2009-2022Leila S Hojat, Brigid M Wilson, Michael J Satlin, et al.
Jac-Antimicrobial Resistance|August 3, 2023
Fixed versus individualized treatment for five common bacterial infectious syndromes: a survey of the perspectives and practices of cliniciansKwadwo Mponponsuo, Ruxandra Pinto, Robert Fowler, et al.
Jac-Antimicrobial Resistance|August 3, 2023
Endemicity of Pseudomonas aeruginosa producing IMP-18 and/or VIM-2 MBLs from the high-risk clone ST111 in Central AmericaLalitagauri M Deshpande, Silvio Vega, Juan Carlos Tinoco, et al.
Pageof 126